{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:24:48Z","timestamp":1792207488541,"version":"4.4.0"},"reference-count":27,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,11]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Disease-modifying therapies are standard of care (SOC) for sickle cell disease (SCD), but hematopoietic cell transplantation (HCT) has curative potential. We compared outcomes prospectively through 2 years after biologic assignment to a donor or no donor (SOC) arm based on the availability of an HLA-matched sibling or unrelated donor (BMT CTN 1503). A donor search was commenced after eligibility confirmation. The primary end point was a comparison of survival between the treatment arms 2 years after biologic assignment. Power calculations required 60 participants in the donor arm and 140 in the no donor arm to determine if early transplant-related mortality might be balanced by disease-related mortality over a longer period of follow-up. Secondary objectives were a comparison of the changes in SCD-related events, functional outcomes, and organ function. The data were analyzed according to the intent-to-treat principle. A total of 113 participants were enrolled with 28 in the donor arm and 85 in the no donor arm. The 2-year probabilities of survival were 89% and 93%, in the donor vs no donor arms. Vaso-occlusive pain (VOC) was less frequent in the donor arm in the second year after biologic assignment (P\u00a0&amp;lt; .001). Based on PROMIS-57 surveys, there was a decrease in fatigue (P\u00a0=\u00a0.003) and an increase in the ability to participate in social roles and activities (P\u00a0=\u00a0.003) in the donor arm 2 years after biologic assignment. Differences in other secondary outcomes did not reach statistical significance. Barriers to accrual prevented an objective comparison of survival. Assignment to the donor arm led to improvements in VOC, fatigue, and social function. This trial was registered at www.clinicaltrials.gov as #NCT02766465.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024013926","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T21:37:05Z","timestamp":1730237825000},"page":"955-965","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":17,"title":["Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6515-4559","authenticated-orcid":false,"given":"Mark C.","family":"Walters","sequence":"first","affiliation":[{"name":"1Department of Pediatrics, Division of Hematology, University of California San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-4243","authenticated-orcid":false,"given":"Mary","family":"Eapen","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Division of Hematology-Oncology, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Liu","sequence":"additional","affiliation":[{"name":"3Department of Data Science, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8583-0526","authenticated-orcid":false,"given":"Fuad","family":"El Rassi","sequence":"additional","affiliation":[{"name":"4Department of Hematology and Medical Oncology, Division of Hematology, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0816-6729","authenticated-orcid":false,"given":"Edmund K.","family":"Waller","sequence":"additional","affiliation":[{"name":"4Department of Hematology and Medical Oncology, Division of Hematology, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5611-7828","authenticated-orcid":false,"given":"John E.","family":"Levine","sequence":"additional","affiliation":[{"name":"5Department of Pediatrics, Division of Hematology Oncology, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0341-1457","authenticated-orcid":false,"given":"John J.","family":"Strouse","sequence":"additional","affiliation":[{"name":"6Department of Medicine, Division of Hematology Oncology, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Antin","sequence":"additional","affiliation":[{"name":"7Hematologic Oncology Treatment Program, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6066-9852","authenticated-orcid":false,"given":"Suhag H.","family":"Parikh","sequence":"additional","affiliation":[{"name":"8Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0876-9506","authenticated-orcid":false,"given":"Nitya","family":"Bakshi","sequence":"additional","affiliation":[{"name":"8Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA"},{"name":"9Department of Pediatrics, Division of Hematology\/Oncology\/BMT, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7738-2620","authenticated-orcid":false,"given":"Carlton","family":"Dampier","sequence":"additional","affiliation":[{"name":"8Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Jaroscak","sequence":"additional","affiliation":[{"name":"10Department of Pediatrics, Division of Hematology\/Oncology\/BMT, Medical University of South Carolina, Charleston, SC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayla","family":"Bergmann","sequence":"additional","affiliation":[{"name":"10Department of Pediatrics, Division of Hematology\/Oncology\/BMT, Medical University of South Carolina, Charleston, SC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5298-6217","authenticated-orcid":false,"given":"Trisha","family":"Wong","sequence":"additional","affiliation":[{"name":"11Division of Hematology and Oncology, School of Medicine, Oregon Health & Science University, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamsi","family":"Kota","sequence":"additional","affiliation":[{"name":"12Department of Medicine, Division of Hematology and Oncology, Medical College of Georgia, Augusta University, Augusta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1275-4112","authenticated-orcid":false,"given":"Betty","family":"Pace","sequence":"additional","affiliation":[{"name":"13Department of Pediatrics, Division of Hematology and Oncology, Medical College of Georgia, Augusta University, Augusta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2077-7032","authenticated-orcid":false,"given":"Lazaros J.","family":"Lekakis","sequence":"additional","affiliation":[{"name":"14Department of Medicine, Division of Hematology\/Oncology\/BMT, University of Miami, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7707-2331","authenticated-orcid":false,"given":"Premal","family":"Lulla","sequence":"additional","affiliation":[{"name":"15Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4277-7523","authenticated-orcid":false,"given":"Robert S.","family":"Nickel","sequence":"additional","affiliation":[{"name":"16Department of Pediatrics, Division of Hematology, Children\u2019s National Hospital, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0651-8666","authenticated-orcid":false,"given":"Kimberly A.","family":"Kasow","sequence":"additional","affiliation":[{"name":"17Department of Pediatrics, Division of Hematology\/Oncology\/BMT, The University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7592-2224","authenticated-orcid":false,"given":"Uday","family":"Popat","sequence":"additional","affiliation":[{"name":"18Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wally","family":"Smith","sequence":"additional","affiliation":[{"name":"19Department of Medicine, Division of General Internal Medicine, Virginia Commonwealth University, Richmond, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lolie","family":"Yu","sequence":"additional","affiliation":[{"name":"20Department of Pediatrics, Division of Hematology\/Oncology\/BMT, Children\u2019s Hospital of New Orleans, New Orleans, LA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"DiFronzo","sequence":"additional","affiliation":[{"name":"21National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0500-7386","authenticated-orcid":false,"given":"Nancy","family":"Geller","sequence":"additional","affiliation":[{"name":"22National Heart, Lung, and Blood Institute, Division of Intramural Research, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1582-8874","authenticated-orcid":false,"given":"Naynesh","family":"Kamani","sequence":"additional","affiliation":[{"name":"23Department of Pediatrics, Division of Immunology, Children\u2019s National Hospital, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4879-720X","authenticated-orcid":false,"given":"Elizabeth S.","family":"Klings","sequence":"additional","affiliation":[{"name":"24Department of Medicine, Division of Hematology and Medical Oncology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1779-6386","authenticated-orcid":false,"given":"Kathryn","family":"Hassell","sequence":"additional","affiliation":[{"name":"25Department of Medicine, Division of Hematology, University of Colorado, Denver, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9742-0329","authenticated-orcid":false,"given":"Adam","family":"Mendizabal","sequence":"additional","affiliation":[{"name":"26Emmes, Rockville, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Sullivan","sequence":"additional","affiliation":[{"name":"27Department of Medicine, Division of Hematologic Malignanices and Cellular Therapy, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2566-3145","authenticated-orcid":false,"given":"Donna","family":"Neuberg","sequence":"additional","affiliation":[{"name":"3Department of Data Science, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3242-0037","authenticated-orcid":false,"given":"Lakshmanan","family":"Krishnamurti","sequence":"additional","affiliation":[{"name":"8Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA"},{"name":"9Department of Pediatrics, Division of Hematology\/Oncology\/BMT, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"issue":"1","key":"2025032513471564700_bib1","doi-asserted-by":"crossref","first-page":"Itc1","DOI":"10.7326\/AITC202101190","article-title":"Sickle cell disease","volume":"174","author":"Pecker","year":"2021","journal-title":"Ann Intern Med"},{"issue":"9","key":"2025032513471564700_bib2","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/ajh.25202","article-title":"Clustering of end-organ disease and earlier mortality in adults with sickle cell disease: a retrospective-prospective cohort study","volume":"93","author":"Chaturvedi","year":"2018","journal-title":"Am J Hematol"},{"issue":"6","key":"2025032513471564700_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1182\/blood-2018-10-880575","article-title":"Decreased median survival of adults with sickle cell disease after adjusting for left truncation bias: a pooled analysis","volume":"133","author":"DeBaun","year":"2019","journal-title":"Blood"},{"issue":"2","key":"2025032513471564700_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/003335491312800206","article-title":"Mortality rates and age at death from sickle cell disease: U.S., 1979-2005","volume":"128","author":"Lanzkron","year":"2013","journal-title":"Public Health Rep"},{"issue":"3","key":"2025032513471564700_bib5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/jama.2018.20059","article-title":"Association of matched sibling donor hematopoietic stem cell transplantation with transcranial doppler velocities in children with sickle cell anemia","volume":"321","author":"Bernaudin","year":"2019 22","journal-title":"JAMA"},{"issue":"6","key":"2025032513471564700_bib6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.bbmt.2018.11.027","article-title":"Haploidentical bone marrow transplantation with post-transplantation cyclophosphamide plus thiotepa improves donor engraftment in patients with sickle cell anemia: results of an International Learning Collaborative","volume":"25","author":"de la Fuente","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2025032513471564700_bib7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1182\/blood.2020005687","article-title":"Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease","volume":"136","author":"Brazauskas","year":"2020","journal-title":"Blood"},{"issue":"4","key":"2025032513471564700_bib8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ajh.25401","article-title":"Bone marrow transplantation for adolescents and young adults with sickle cell disease: results of a prospective multicenter pilot study","volume":"94","author":"Krishnamurti","year":"2019","journal-title":"Am J Hematol"},{"issue":"6","key":"2025032513471564700_bib9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajh.21699","article-title":"The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up","volume":"85","author":"Steinberg","year":"2010","journal-title":"Am J Hematol"},{"issue":"1","key":"2025032513471564700_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2014.7192","article-title":"Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype","volume":"312","author":"Hsieh","year":"2014","journal-title":"JAMA"},{"issue":"21","key":"2025032513471564700_bib11","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1182\/blood-2016-05-715870","article-title":"A\u00a0trial of unrelated donor marrow transplantation for children with severe sickle cell disease","volume":"128","author":"Shenoy","year":"2016","journal-title":"Blood"},{"issue":"9","key":"2025032513471564700_bib12","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.bbmt.2019.05.015","article-title":"Dynamic graft-versus-host disease-free, relapse-free survival: multistate modeling of the morbidity and mortality of allotransplantation","volume":"25","author":"Holtan","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"282","key":"2025032513471564700_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J\u00a0Am Stat Assoc"},{"key":"2025032513471564700_bib14","author":"Greenwood","year":"1926"},{"issue":"3","key":"2025032513471564700_bib15","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A\u00a0class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Statist"},{"issue":"6","key":"2025032513471564700_bib16","doi-asserted-by":"crossref","first-page":"325.e1","DOI":"10.1016\/j.jtct.2022.03.014","article-title":"Long-term survival after hematopoietic cell transplant for sickle cell disease compared to the United States population","volume":"28","author":"St Martin","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"2025032513471564700_bib17","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/ajh.27251","article-title":"Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial","volume":"99","author":"Eapen","year":"2024","journal-title":"Am J Hematol"},{"issue":"11","key":"2025032513471564700_bib18","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(19)30154-1","article-title":"Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study","volume":"6","author":"Eapen","year":"2019","journal-title":"Lancet Haematol"},{"issue":"12","key":"2025032513471564700_bib19","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1200\/JCO.22.01203","article-title":"Secondary neoplasms after hematopoietic cell transplant for sickle cell disease","volume":"41","author":"Eapen","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"2025032513471564700_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"2025032513471564700_bib21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2117175","article-title":"Biologic and clinical efficacy of LentiGlobin for sickle cell disease","volume":"386","author":"Kanter","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"2025032513471564700_bib22","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJMoa2309676","article-title":"Exagamglogene autotemcel for severe sickle cell disease","volume":"390","author":"Frangoul","year":"2024","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"2025032513471564700_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.bbmt.2015.08.036","article-title":"Nonmyeloablative stem cell transplantation with alemtuzumab\/low-dose irradiation to cure and improve the quality of life of adults with sickle cell disease","volume":"22","author":"Saraf","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2025032513471564700_bib24","first-page":"183","article-title":"Understanding pain and improving management of sickle cell disease: the PiSCES study","volume":"97","author":"Smith","year":"2005","journal-title":"J\u00a0Natl Med Assoc"},{"issue":"4","key":"2025032513471564700_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jtct.2022.10.008","article-title":"Enrollment lessons from a biological assignment study of marrow transplantation versus standard care for adolescents and young adults with sickle cell disease: considerations for future gene and cellular therapy trials","volume":"29","author":"Krishnamurti","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"2025032513471564700_bib26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"2025032513471564700_bib27","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/pbc.25439","article-title":"Allogeneic donor availability for hematopoietic stem cell transplantation in children with sickle cell disease","volume":"62","author":"Justus","year":"2015","journal-title":"Pediatr Blood Cancer"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/5\/955\/2357082\/blooda_adv-2024-013926-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/5\/955\/2357082\/blooda_adv-2024-013926-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T22:32:02Z","timestamp":1742941922000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/5\/955\/525812\/Hematopoietic-cell-transplant-compared-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,3,11]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024013926","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]}}}